Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 10, 2021

BUY
$33.54 - $40.55 $398,354 - $481,612
11,877 New
11,877 $398,000
Q2 2019

Aug 14, 2019

SELL
$62.09 - $86.14 $1.64 Million - $2.27 Million
-26,408 Closed
0 $0
Q1 2019

May 10, 2019

SELL
$52.92 - $81.17 $434,261 - $666,081
-8,206 Reduced 23.71%
26,408 $2.14 Million
Q4 2018

Feb 12, 2019

BUY
$43.37 - $59.54 $1.5 Million - $2.06 Million
34,614 New
34,614 $1.87 Million

Others Institutions Holding IONS

About IONIS PHARMACEUTICALS INC


  • Ticker IONS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 141,940,992
  • Market Cap $5.64B
  • Description
  • Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...
More about IONS
Track This Portfolio

Track Hap Trading, LLC Portfolio

Follow Hap Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hap Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hap Trading, LLC with notifications on news.